Holocene Advisors, LP Ultragenyx Pharmaceutical Inc. Transaction History

Holocene Advisors, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$48.54 - $85.31 $234,351 - $411,876	-4,828 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$44.33 - $58.52 $571,502 - $754,439	-12,892 Reduced 72.75%	4,828 $246,000
Q4 2017 Feb 14, 2018	BUY	$43.54 - $57.32 $771,528 - $1.02 Million	17,720	17,720 $822,000

287

88.1M

505K

198K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.89B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.